Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

0.574
Delayed Data
As of Nov 22
 -0.016 / -2.71%
Today’s Change
0.55
Today|||52-Week Range
3.10
-72.67%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close0.59
Today’s open0.61
Day’s range0.55 - 0.61
Volume500,754
Average volume (3 months)563,412
Market cap$21.9M
Dividend yield--
Data as of 3:59pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-13.22%
Earnings growth (this year)+40.15%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+21.82%
P/E ratioNM
Price/Sales166.87
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
ONCSOncoSec Medical Inc+0.19+9.45%
MBOTMicrobot Medical Inc-0.03-2.48%
--BARD1 Life Sciences ...0.000.00%
PTIProteostasis Therape...-0.08-4.10%
Data as of 11/23/2017

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$381.1K
Annual profit (last year)-$39.2M
Net profit margin-10,287.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bill Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts